Ibandronic Acid [kyselina ibandronová]
- Terms
-
Bondronat
Bonviva
ibandronát
ibandronát sodný
monohydrát ibandronátu sodného
monohydrát sodné soli kyseliny ibandronové
-
(1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate
BM 21.0955
BM 210955
BM-21.0955
BM-210955
Bondronat
Boniva
Bonviva
Ibandronate
Ibandronate Sodium
Ibandronate Sodium Anhydrous
Ibandronic Acid, Sodium Salt, Monohydrate
RPR 102289A
RPR-102289A
Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
- DUI
- D000077557 MeSH Browser
- CUI
- M0197524
- CAS
- Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-
- History note
- 2019 (1992)
- Public note
- 2019; IBANDRONIC ACID was indexed under DIPHOSPHONATES 1992-2018
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 2
- TO
- toxicity 0
- UR
- urine 0